Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 7/20 | 0.52 |
| ▸ | CTSK | P43235 | 6/20 | 0.52 |
| ▸ | AAK1 | Q2M2I8 | 7/20 | 0.48 |
| ▸ | CTSB | P07858 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | TACR1 | P25103 | 2/20 | 0.43 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21732907 | 1.00 | CTSS (0.52) | CTSSCTSKAAK1CTSBALDH1A1 | |
| SCHEMBL21722664 | 1.00 | CTSS (0.52) | CTSSCTSKAAK1CTSBALDH1A1 | |
| SCHEMBL18179194 | 0.89 | AAK1 (0.51) | CTSSCTSKAAK1CTSBALDH1A1 | |
| SCHEMBL18179185 | 0.88 | CTSS (0.49) | CTSSCTSKAAK1CTSBALDH1A1 | |
| SCHEMBL26372576 | 0.88 | CTSS (0.50) | CTSSCTSKAAK1CTSBALDH1A1 | |
| SCHEMBL18170221 | 0.88 | AAK1 (0.52) | CTSSCTSKAAK1CTSBALDH1A1 | |
| SCHEMBL18170254 | 0.88 | AAK1 (0.54) | CTSSCTSKAAK1CTSBALDH1A1 | |
| SCHEMBL28340282 | 0.88 | AAK1 (0.52) | CTSSCTSKAAK1CTSBALDH1A1 | |
| SCHEMBL17258264 | 0.84 | AAK1 (0.44) | CTSSCTSKAAK1CTSBALDH1A1 | |
| SCHEMBL17258263 | 0.84 | AAK1 (0.44) | CTSSCTSKAAK1CTSBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12331067-B2 | Method for preparing 18F-BPA and intermediate | NEUBORON MEDTECH LTD. (CN) | 2025-06-17 | — | — | US | disclosed |
| CN-112979684-B | Preparation 18 F-BPA process | 南京江原安迪科正电子研究发展有限公司 | 2023-11-03 | — | — | CN | disclosed |
| EP-3838890-B1 | METHOD FOR PREPARING 18F-BPA AND INTERMEDIATE | NEUBORON MEDTECH LTD (CN) | 2023-10-04 | — | — | EP | disclosed |
| US-20230242555-A1 | METHOD FOR PREPARING 18F-BPA AND INTERMEDIATE | NEUBORON MEDTECH LTD. (CN) | 2023-08-03 | — | — | US | disclosed |
| US-20230242555-A1 | METHOD FOR PREPARING 18F-BPA AND INTERMEDIATE | NEUBORON MEDTECH LTD. (CN) | 2023-08-03 | — | — | US | disclosed |
| US-20230242555-A1 | METHOD FOR PREPARING 18F-BPA AND INTERMEDIATE | NEUBORON MEDTECH LTD. (CN) | 2023-08-03 | — | — | US | disclosed |
| US-11655261-B2 | Method for preparing 18F-BPA and intermediate | NEUBORON MEDTECH LTD. (CN) | 2023-05-23 | — | — | US | disclosed |
| US-11655261-B2 | Method for preparing 18F-BPA and intermediate | NEUBORON MEDTECH LTD. (CN) | 2023-05-23 | — | — | US | disclosed |
| US-11655261-B2 | Method for preparing 18F-BPA and intermediate | NEUBORON MEDTECH LTD. (CN) | 2023-05-23 | — | — | US | disclosed |
| CN-110835310-B | Intermediate, preparation method and application | 南京中硼联康医疗科技有限公司 | 2022-09-20 | — | — | CN | disclosed |
| CN-110835352-B | Preparation method18Process for F-BPA | 南京中硼联康医疗科技有限公司 | 2022-05-24 | — | — | CN | disclosed |
| CN-113773337-A | Radiolabeled boron-containing compounds, methods of preparation and uses | 南京中硼联康医疗科技有限公司 | 2021-12-10 | — | — | CN | disclosed |
| US-20210230192-A1 | METHOD FOR PREPARING 18F-BPA AND INTERMEDIATE | NEUBORON MEDTECH LTD. (CN) | 2021-07-29 | — | — | US | disclosed |
| CN-113045592-A | 18Process for the preparation of F-BPA | 南京江原安迪科正电子研究发展有限公司 | 2021-06-29 | — | — | CN | disclosed |
| EP-3838890-A1 | METHOD FOR PREPARING 18F-BPA AND INTERMEDIATE | Neuboron Medtech Ltd. (CN) | 2021-06-23 | — | — | EP | disclosed |
| CN-112979684-A | Preparation of18Process for F-BPA | 南京江原安迪科正电子研究发展有限公司 | 2021-06-18 | — | — | CN | disclosed |
| CN-110835352-A | Preparation method18Process for F-BPA | 南京中硼联康医疗科技有限公司 | 2020-02-25 | — | — | CN | disclosed |
| CN-110835310-A | Intermediate, preparation method and application | 南京中硼联康医疗科技有限公司 | 2020-02-25 | — | — | CN | disclosed |
| WO-2020035011-A1 | METHOD FOR PREPARING 18F-BPA AND INTERMEDIATE | 南京中硼联康医疗科技有限公司 | 2020-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242555-A1 | METHOD FOR PREPARING 18F-BPA AND INTERMEDIATE | CYP19A1, SHBG, ESR1 | CTSS 1606/4885CTSK 1792/4885AAK1 2159/4885 |
| US-12331067-B2 | Method for preparing 18F-BPA and intermediate | CYP19A1, SHBG, ESR1 | CTSS 1606/4885CTSK 1792/4885AAK1 2159/4885 |
| US-20210230192-A1 | METHOD FOR PREPARING 18F-BPA AND INTERMEDIATE | CYP19A1, SHBG, ESR1 | CTSS 1606/4885CTSK 1792/4885AAK1 2159/4885 |
| US-11655261-B2 | Method for preparing 18F-BPA and intermediate | CYP19A1, SHBG, ESR1 | CTSS 1606/4885CTSK 1792/4885AAK1 2159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.